Bonakdar Robert Alan, Sweeney Megan, Dalhoumi Sarah, Adair Vanessa, Garvey Cathy, Hodge Teresa, Herrala Leslie, Barbee Ali, Case Christina, Kearney Joe, Smith Kendall, Hwang Jacob
Drs. Smith and Hwang contributed while at Bastyr University California, San Diego, California.
Integr Med (Encinitas). 2020 Oct;19(5):16-28.
Obesity is a complex multifactorial disorder affecting a growing proportion of the population. While therapeutic lifestyle change (TLC) is foundational, results of interventional programs are often inconsistent. Factors related to systemic inflammation, toxin load and endotoxemia have been postulated to play a contributory role. This pilot study sought to evaluate the role of TLC with enhanced laboratory evaluation and interventions to address these emerging therapeutic targets.
Twelve participants with a body mass index (BMI) greater than 30 (or 27 with metabolic co-morbidities) were recruited from an outpatient clinic for participation with a primary outcome of pre/post changes in body composition. Participants completed a 12-week program involving weekly group and individualized dietary, exercise, and behavioral support, supplemented with a commercial, 30-day dietary detoxification intervention and ongoing nutritional counseling. All participants completed baseline and post-intervention evaluation including metabolic, toxin load, endotoxin, body composition and functional fitness profiles.
After 12-weeks, participants as a group significantly improved body composition parameters including BMI, body fat, fat mass, and waist and hip circumference ( < .01). Significant improvement in several secondary outcomes including levels of lipopolysaccharide, zonulin and leptin were noted. Additionally, results demonstrate substantial improvements in pain, pain interference and functional fitness. Upon completion, all participants rated the program favorably with a high likelihood of continuing or recommending participation to others.
Obesity remains a challenging and often refractory clinical scenario with emerging evidence indicating the potential role of systemic inflammation, toxin load and endotoxemia. A group therapeutic lifestyle change program enhanced with a detoxification component is feasible and may provide a promising intervention for achieving weight loss while also addressing functional and pain related co-morbidities. Future randomized trials evaluating the components of such a program are needed to better delineate the role of specific interventions in the complex setting of obesity.
肥胖是一种复杂的多因素疾病,影响着越来越多的人群。虽然治疗性生活方式改变(TLC)是基础,但干预项目的结果往往不一致。与全身炎症、毒素负荷和内毒素血症相关的因素被认为起了促成作用。这项初步研究旨在评估TLC结合强化实验室评估和干预措施对这些新出现的治疗靶点的作用。
从门诊招募了12名体重指数(BMI)大于30(或有代谢合并症的BMI大于27)的参与者,主要观察指标是身体成分的前后变化。参与者完成了一个为期12周的项目,包括每周的小组和个性化饮食、运动及行为支持,并辅以一个为期30天的商业饮食排毒干预和持续的营养咨询。所有参与者完成了基线和干预后的评估,包括代谢、毒素负荷、内毒素、身体成分和功能健康状况。
12周后,参与者作为一个整体,身体成分参数显著改善,包括BMI、体脂、脂肪量以及腰围和臀围(P<0.01)。观察到几个次要结果有显著改善,包括脂多糖、闭合蛋白和瘦素水平。此外,结果表明疼痛、疼痛干扰和功能健康状况有实质性改善。项目结束时,所有参与者对该项目评价良好,很有可能继续参与或推荐他人参与。
肥胖仍然是一个具有挑战性且常常难以治疗的临床情况,新出现的证据表明全身炎症、毒素负荷和内毒素血症可能起作用。一个结合排毒成分的团体治疗性生活方式改变项目是可行的,可能为实现体重减轻同时解决功能和疼痛相关合并症提供一个有前景的干预措施。未来需要进行随机试验来评估这样一个项目的各个组成部分,以便更好地阐明特定干预措施在肥胖这种复杂情况下的作用。